Promoter methylation of RB1, P15, P16, and MGMT and their impact on the clinical course of pilocytic astrocytomas.

about

Promoter methylation of RB1, P15, P16, and MGMT and their impact on the clinical course of pilocytic astrocytomas.

Item

http://www.wikidata.org/entity/Q49645086

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Promoter methylation of RB1, P ...... rse of pilocytic astrocytomas.

@en

Promoter methylation of RB1, P ...... rse of pilocytic astrocytomas.

@nl

type

Item

label

Promoter methylation of RB1, P ...... rse of pilocytic astrocytomas.

@en

Promoter methylation of RB1, P ...... rse of pilocytic astrocytomas.

@nl

prefLabel

Promoter methylation of RB1, P ...... rse of pilocytic astrocytomas.

@en

Promoter methylation of RB1, P ...... rse of pilocytic astrocytomas.

@nl

P1476

Promoter methylation of RB1, P ...... rse of pilocytic astrocytomas.

@en

P2093

Christoph Sippl

http://www.w3.org/2001/XMLSchema#string

Joachim Oertel

http://www.w3.org/2001/XMLSchema#string

Ralf Ketter

http://www.w3.org/2001/XMLSchema#string

Sebastian Senger

http://www.w3.org/2001/XMLSchema#string

Steffi Urbschat

http://www.w3.org/2001/XMLSchema#string

Yoo Jin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

Methylation analyses in liquid biopsy

Deletion of p16 and p15 genes in brain tumors

[Childhood diencephalic pilocytic astrocytoma. A review of seven observations].

From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation.

Adult pilocytic astrocytomas: clinical features and molecular analysis

Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.

A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702)

Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment.

The expression of mismatched repair genes and their correlation with clinicopathological parameters and response to neo-adjuvant chemotherapy in breast cancer

P304

1600-1606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.7490

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29434855

http://www.w3.org/2001/XMLSchema#string

P932

5776924

http://www.w3.org/2001/XMLSchema#string